Level Up Your BUD Game: An Interactive, Choose Your Own Adventure Activity on Beyond Use Dates in Sterile Compounding
ACPE Number:0204-0000-26-403-H07-P/T Content Release Date: June 15, 2026 Expiration Date: June 15, 2027 Activity Type: Application-based CE Credits: 0.75 contact hours (0.075 CEUs) Activity Fee: Free
Activity Overview
The United States Pharmacopeia General Chapter 797 (USP <797>) defines the minimum standards for sterile compounding that are critical for patient safety. This educational activity will focus on the practical application of these standards when assigning beyond-use dates (BUDs) for compounded sterile preparations (CSPs). Pharmacists, pharmacy technicians, and medication safety officers frequentlyencounter challenges when determining appropriate BUDs due to variations in compounding environments, facility compliance levels, and operational workflows. Participants will explore how BUD determinations may differ across practice settings such as fully compliant cleanroom suites and segregated compounding areas. In this interactive web-based activity, learners will apply these concepts to real-world situations, reinforcing how facility-specific conditions can impact appropriate BUD selection for CSPs.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems, including all settings responsible for preparing, labeling, packaging, storing, and distributing compounded sterile preparations.
Patricia C. Kienle, MPA, BCSCP, FASHP, is Director of Accreditation and Medication Safety for Cardinal Health. She received her pharmacy degree from Philadelphia College of Pharmacy and Science and a Master in Public Administration degree from Marywood University in Scranton, Pennsylvania. She is author of The Chapter <795> Answer Book, The Chapter <797> Answer Book, and The Chapter <800> Answer Book and co-author of Meeting Accreditation Standards: A Pharmacy Preparation Guide. With over 750 invited presentations and 100 publications, she has special interests in medication safety, compounding sterile preparations, accreditation, and regulatory issues.
George R. Smith, PharmD, BCPS, BCSCP System Sterile Compounding Services Specialist Prisma Health Department of Pharmacy Columbia, South Carolina
George R. Smith, PharmD, BCPS, BCSCP, is currently serving as the System Sterile Compounding Services Specialist at Prisma Health, a 3200-bed health-system in South Carolina and Tennessee. Dr. Smith is also serving as a Clinical Instructor of Sterile Compounding for the Kennedy Pharmacy Innovation Center at the University of South Carolina College of Pharmacy. Dr. Smith is a current member of the ASHP Section of Inpatient Pharmacists Section Advisory Group for Compounding Practice, an AJHP peer reviewer, and a field-tester for ASHP’s Compounded Sterile Preparation Intensive Studies for Recertification. Additionally, Dr. Smith is a member of the USP Compounding Expert Committee for the 2025-2030 cycle.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
Patricia C. Kienle: Ownership of stock – Abbott, Abbvie, Amgen, BD, Bristol Myers Squibb, CVS Health, Johnson and Johnson, Merck, and Organon
George R. Smith: Consultant –Intelliguard, ARxIUM
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
To receive CE credit, complete the steps below within 60 days of completing the activity.
View the entire presentation.
Click "Complete Activity" on last slide then complete the evaluation to claim credit.
Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.
Important Note – ACPE 60 Day Deadline Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.
Provided by ASHP.
Supported by an educational grant from Pfizer, Inc.
